Next Article in Journal
Diagnosis of Desmoplastic Reaction by Immunohistochemical Analysis, in Biopsy Specimens of Early Colorectal Carcinomas, Is Efficacious in Estimating the Depth of Invasion
Next Article in Special Issue
(Healthy) Ageing: Focus on Iodothyronines
Previous Article in Journal
Protective Effects of Hydrogen Sulfide in Hypoxic Human Umbilical Vein Endothelial Cells: A Possible Mitochondria-Dependent Pathway
Previous Article in Special Issue
Individual and Joint Impacts of Ethanol Use, BMI, Age and Gender on Serum Gamma-Glutamyltransferase Levels in Healthy Volunteers
Article Menu

Export Article

Open AccessReview

Hormesis in Aging and Neurodegeneration—A Prodigy Awaiting Dissection

Department of Life Science Engineering, HTW Berlin, University of Applied Sciences, Wilhelminenhofstraße 75A, Berlin 12459, Germany
Institute of Medical Genetics and Human Genetics, Charité—Universitätsmedizin Berlin, Augustenbruger Platz 1, Berlin 13353, Germany
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(7), 13109-13128;
Received: 11 March 2013 / Revised: 16 May 2013 / Accepted: 17 May 2013 / Published: 25 June 2013
(This article belongs to the Special Issue Oxidative Stress and Ageing)
PDF [736 KB, uploaded 19 June 2014]


Hormesis describes the drug action of low dose stimulation and high dose inhibition. The hormesis phenomenon has been observed in a wide range of biological systems. Although known in its descriptive context, the underlying mode-of-action of hormesis is largely unexplored. Recently, the hormesis concept has been receiving increasing attention in the field of aging research. It has been proposed that within a certain concentration window, reactive oxygen species (ROS) or reactive nitrogen species (RNS) could act as major mediators of anti-aging and neuroprotective processes. Such hormetic phenomena could have potential therapeutic applications, if properly employed. Here, we review the current theories of hormetic phenomena in regard to aging and neurodegeneration, with the focus on its underlying mechanism. Facilitated by a simple mathematical model, we show for the first time that ROS-mediated hormesis can be explained by the addition of different biomolecular reactions including oxidative damage, MAPK signaling and autophagy stimulation. Due to their divergent scales, the optimal hormetic window is sensitive to each kinetic parameter, which may vary between individuals. Therefore, therapeutic utilization of hormesis requires quantitative characterizations in order to access the optimal hormetic window for each individual. This calls for a personalized medicine approach for a longer human healthspan. View Full-Text
Keywords: hormesis; aging; neurodegenerative diseases (ND); reactive oxygen species (ROS); reactive nitrogen species (RNS); mathematical modeling; personalized medicine hormesis; aging; neurodegenerative diseases (ND); reactive oxygen species (ROS); reactive nitrogen species (RNS); mathematical modeling; personalized medicine

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Mao, L.; Franke, J. Hormesis in Aging and Neurodegeneration—A Prodigy Awaiting Dissection. Int. J. Mol. Sci. 2013, 14, 13109-13128.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top